It is a dubious disease in the field of infectious respiratory digestive and endocrine disorders, where clinical performance is complex and often involves multi-system fatigue. Early identification and standardized diagnosis are critical to improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological activation.
The platform can assist in linking a team of domestic and foreign authorities to provide accurate diagnosis and treatment programs. Treatment and management of PF-ILDs require individual treatment alternatives, usually including pharmacotherapy, rehabilitation interventions, regular follow-up, and more. In recent years, with the development of treatment-focused, immune-regulatory therapy and precision medicine, many previously difficult to treat infectious respiratory digestive endocrine disorders have been significantly improved.
Treatment requires close monitoring of therapeutic effects and adverse reactions, adapting to timely schemes based on disease changes. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of PF-ILD-associated ilticon. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.